A 33-year follow-up after valvular surgery for carcinoid heart disease

Johannes Bergsten1,2, Frank A Flachskampf1,2, Lennart Lundin1,2

  • 1Department of Clinical Physiology and Cardiology, University Hospital, Uppsala, Sweden.

Insights

Valvular surgery for carcinoid heart disease (CaHD) improves survival, especially with combined tricuspid and pulmonary valve replacement. Biomarkers like NT-pro-BNP and 5-HIAA predict poor outcomes in CaHD patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Oncology

Background:

  • Carcinoid heart disease (CaHD) involves valvular damage, primarily affecting the tricuspid and pulmonary valves.
  • Surgical intervention for severe CaHD has improved long-term prognosis, but data on survival predictors and optimal surgical strategy remain limited.

Purpose of the Study:

  • To review survival and echocardiographic findings in patients who underwent valvular surgery for severe CaHD.
  • To identify predictors of survival and evaluate the strategy of single versus double-valve surgery in CaHD.

Main Methods:

  • Retrospective review of 60 consecutive patients with severe CaHD undergoing valve surgery between 1986 and 2019.
  • Analysis included preoperative echocardiography, creatinine, NT-pro-brain natriuretic peptide (NT-pro-BNP), and 24-h urinary 5-hydroxyindoleacetic acid (5-HIAA).
  • Surgical procedures were categorized into combined tricuspid valve replacement (TVR) and pulmonary valve replacement (PVR) versus TVR-only or TVR with pulmonary valvotomy.

Main Results:

  • 30-day mortality was 12%, decreasing to 8% in the most recent decade (2010-2019). Median survival was 2.2 years.
  • Combined TVR and PVR demonstrated significantly higher survival rates (median 3.0 years) compared to operations without PVR (median 0.9 years).
  • Elevated preoperative NT-pro-BNP and 5-HIAA levels in the top quartile were associated with poor survival. Preoperative echocardiography sometimes underestimated pulmonary valve pathology.

Conclusions:

  • Valvular surgery for CaHD is associated with acceptable perioperative risk.
  • Combined TVR and PVR should be considered for most CaHD patients due to improved survival outcomes.
  • Bioprosthetic valves show adequate durability relative to the oncological life expectancy of CaHD patients.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
74
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
76
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
114
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
86
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
97
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
111